Medical Marijuana Course

Lesson 1 • Cannabis Plant Biology

Covers taxonomy, anatomy, and growth cycles of Cannabis sativa, indica, and ruderalis. Builds botanical literacy essential for understanding product variation.

Lesson 2 • Key Cannabinoids and Compounds

Identifies primary and minor cannabinoids, terpenes, and flavonoids. Establishes chemical literacy needed for dosing, product selection, and patient counseling.

Lesson 3 • The Endocannabinoid System

Explains the body's native endocannabinoid system, receptors, and endogenous ligands. Connects plant compounds to human physiology as the basis for therapeutic action.

Lesson 4 • History and Cultural Context

Traces cannabis use from ancient medicine to modern therapeutic acceptance. Provides historical grounding that contextualizes current medical and regulatory frameworks.

Lesson 1 • Patient Qualification and Registration

Details qualifying conditions, physician certification, and patient registry processes. Ensures practitioners understand eligibility gatekeeping and documentation requirements.

Lesson 2 • Ethical and Legal Boundaries in Practice

Addresses conflicts of interest, scope of practice, and liability exposure for medical cannabis professionals. Reinforces ethical decision-making within legal constraints.

Lesson 3 • Licensing for Businesses and Practitioners

Covers license types, application requirements, and ongoing compliance for dispensaries and clinicians. Connects regulatory knowledge to operational readiness.

Lesson 4 • Overview of Regulatory Structures

Maps the layers of government authority governing medical cannabis programs. Clarifies how federal, regional, and local rules interact and create compliance obligations.

Lesson 1 • Pharmacokinetics by Route of Administration

Compares absorption rates, onset times, and duration across inhalation, oral, sublingual, and topical routes. Directly informs route selection for specific patient needs.

Lesson 2 • Special Populations Pharmacology

Addresses pharmacokinetic and pharmacodynamic differences in pediatric, geriatric, and pregnant populations. Guides risk-benefit analysis for vulnerable patient groups.

Lesson 3 • Drug-Drug Interactions

Identifies clinically significant interactions between cannabinoids and common medications. Equips practitioners to screen for interaction risks before recommending cannabis.

Lesson 4 • Pharmacodynamics and Receptor Interactions

Explains how cannabinoids bind receptors, produce effects, and interact with other neurotransmitter systems. Builds mechanistic understanding behind therapeutic and adverse outcomes.

Lesson 1 • Oncology and Palliative Care

Explores cannabis in cancer symptom management, end-of-life comfort, and quality-of-life improvement. Addresses goals-of-care conversations in palliative settings.

Lesson 2 • Pain Management Applications

Reviews evidence for cannabis in neuropathic, inflammatory, and cancer-related pain. Positions cannabis within multimodal pain management strategies.

Lesson 3 • Neurological and Psychiatric Conditions

Examines cannabis use in epilepsy, multiple sclerosis, PTSD, and anxiety disorders. Balances therapeutic potential against psychiatric risk factors.

Lesson 4 • Gastrointestinal and Appetite Disorders

Covers cannabis applications in nausea, cachexia, Crohn's disease, and IBS. Links endocannabinoid gut function to therapeutic rationale.

Lesson 1 • Topical and Transdermal Products

Reviews creams, patches, and gels for localized and systemic delivery. Clarifies when topical routes achieve systemic vs. local therapeutic effects.

Lesson 2 • Concentrates and Extracts

Introduces wax, shatter, rosin, distillate, and isolate concentrate formats. Addresses potency risks and appropriate patient populations for concentrate use.

Lesson 3 • Flower and Inhalation Products

Covers dried flower, pre-rolls, and vaporization devices as inhalation delivery methods. Addresses onset advantages and respiratory risk considerations.

Lesson 4 • Pharmaceutical-Grade Cannabis Products

Covers approved cannabinoid medications, standardized formulations, and regulatory approval pathways. Distinguishes pharmaceutical products from dispensary products.

Lesson 1 • Comprehensive Patient Intake Assessment

Structures the initial patient evaluation including medical history, current medications, and cannabis experience. Creates a complete clinical picture before any recommendation is made.

Lesson 2 • Dosing Principles and Titration

Applies start-low, go-slow titration methodology across product types and patient profiles. Reduces adverse event risk while achieving therapeutic thresholds.

Lesson 3 • Monitoring and Outcome Tracking

Establishes follow-up protocols, validated symptom scales, and adverse event monitoring. Enables data-driven adjustments to optimize patient outcomes over time.

Lesson 4 • Establishing Treatment Goals

Guides practitioners in defining measurable therapeutic targets with patients. Aligns product selection and dosing strategy to specific, patient-centered outcomes.

Lesson 1 • Handling Adverse Events in the Dispensary

Prepares staff to recognize, respond to, and document adverse events occurring at or after dispensary visits. Ensures patient safety and regulatory compliance.

Lesson 2 • Product Knowledge for Counseling

Equips staff with deep product knowledge to match patient needs to available inventory. Connects product attributes to therapeutic goals discussed in prior chapters.

Lesson 3 • Dispensary Workflow and Inventory Management

Covers intake verification, product handling, inventory control, and point-of-sale compliance. Builds operational fluency in a regulated dispensary environment.

Lesson 4 • Effective Patient Communication

Develops plain-language communication skills for diverse patient populations. Reduces misuse risk through clear, empathetic, and culturally sensitive counseling.

Lesson 1 • Public Health Surveillance and Reporting

Covers adverse event surveillance, mandatory reporting obligations, and program outcome monitoring. Positions practitioners as contributors to population-level safety data.

Lesson 2 • Harm Reduction Strategies

Applies harm reduction principles to minimize cannabis-related harms at individual and community levels. Bridges clinical practice with public health responsibility.

Lesson 3 • Adverse Effects and Toxicology

Catalogs acute and chronic adverse effects of cannabis across organ systems. Provides the toxicological foundation for risk communication and clinical decision-making.

Lesson 4 • Dependence, Withdrawal, and Addiction

Explains cannabis use disorder, withdrawal syndrome, and evidence-based management approaches. Prepares practitioners to screen, counsel, and refer appropriately.